Prostate Cancer - Results from #22720

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial - Abstract August 30, 2013

Metastatic castration-resistant prostate cancer: Integrating new learnings to optimise treatment outcomes - Abstract August 30, 2013

Painful boney metastases - Abstract August 29, 2013

Molecularly targeted agents as radiosensitizers in cancer therapy-focus on prostate cancer - Abstract August 29, 2013

Predictors of Gleason score upgrading in a large African-American population - Abstract August 29, 2013

The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in perspective - Abstract August 29, 2013

Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer - Abstract August 29, 2013

Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: Retrospective analysis of safety profile and effect on blood coagulation - Abstract August 29, 2013

Prostate-specific antigen testing: Men's responses to 2012 recommendation against screening - Abstract August 29, 2013

Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxel - Abstract August 29, 2013

New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical - Abstract August 29, 2013

Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy - Abstract August 29, 2013

PSA-based screening for prostate cancer: A comparative analysis - Abstract August 29, 2013

The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: The North Carolina-Louisiana Prostate Cancer Project - Abstract August 29, 2013

The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy - Abstract August 29, 2013

Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: Impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program - Abstract August 29, 2013

A pilot study of Laparoscopic Doppler ultrasound probe to map arterial vascular flow within the neurovascular bundle during robot-assisted radical prostatectomy - Abstract August 28, 2013

Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer - Abstract August 28, 2013

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer - Abstract August 28, 2013

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml - Abstract August 28, 2013

Page 1137 of 1452